126 related articles for article (PubMed ID: 1404658)
1. Progression delay of prostate tumor skeletal metastasis effects by bisphosphonates.
Sun YC; Geldof AA; Newling DW; Rao BR
J Urol; 1992 Oct; 148(4):1270-3. PubMed ID: 1404658
[TBL] [Abstract][Full Text] [Related]
2. Prostatic tumor (R3327) skeletal metastasis.
Geldof AA; Rao BR
Prostate; 1990; 16(4):279-90. PubMed ID: 2371174
[TBL] [Abstract][Full Text] [Related]
3. The use of bisphosphonates in prostatic cancer.
Mason MD; Glaholm J; Dearnaley DP
Clin Oncol (R Coll Radiol); 1994; 6(2):77-8. PubMed ID: 8018576
[No Abstract] [Full Text] [Related]
4. Radionuclide therapy for prostate cancer lumbar metastasis prolongs symptom-free survival in a rat model.
Geldof AA; van den Tillaar PL; Newling DW; Teule GJ
Urology; 1997 May; 49(5):795-801. PubMed ID: 9145995
[TBL] [Abstract][Full Text] [Related]
5. Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results.
Roudier MP; Vesselle H; True LD; Higano CS; Ott SM; King SH; Vessella RL
Clin Exp Metastasis; 2003; 20(2):171-80. PubMed ID: 12705638
[TBL] [Abstract][Full Text] [Related]
6. Oral bisphosphonates: A review of clinical use in patients with bone metastases.
Major PP; Lipton A; Berenson J; Hortobagyi G
Cancer; 2000 Jan; 88(1):6-14. PubMed ID: 10618600
[TBL] [Abstract][Full Text] [Related]
7. Factors in prostate cancer metastasis.
Geldof AA; Rao BR
Anticancer Res; 1990; 10(5A):1303-6. PubMed ID: 2241106
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates in prostate carcinoma.
Adami S
Cancer; 1997 Oct; 80(8 Suppl):1674-9. PubMed ID: 9362435
[TBL] [Abstract][Full Text] [Related]
9. [Bisphosphonates and bone metastases].
Lortholary A; Jadaud E; Berthaud P
Bull Cancer; 1999 Sep; 86(9):732-8. PubMed ID: 10519966
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates and breast carcinoma.
Lipton A
Cancer; 1997 Oct; 80(8 Suppl):1668-73. PubMed ID: 9362434
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates spearhead new approach to treating bone metastases.
Bankhead C
J Natl Cancer Inst; 1997 Jan; 89(2):115-6. PubMed ID: 8998176
[No Abstract] [Full Text] [Related]
12. [Efficiency of second-generation bisphosphonate in treating patients with prostate cancer and bone metastases].
Musaev TN; Kerimov AKh; Ali-zade AM
Georgian Med News; 2008 Nov; (164):14-8. PubMed ID: 19075335
[TBL] [Abstract][Full Text] [Related]
13. Clinical trials test bisphosphonates in hormone-sensitive prostate cancer.
Bankhead C
J Natl Cancer Inst; 2003 Sep; 95(17):1273-4. PubMed ID: 12953081
[No Abstract] [Full Text] [Related]
14. The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model.
Yang M; Burton DW; Geller J; Hillegonds DJ; Hastings RH; Deftos LJ; Hoffman RM
Clin Cancer Res; 2006 Apr; 12(8):2602-6. PubMed ID: 16638872
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy.
Coleman RE
Oncology (Williston Park); 1991 Aug; 5(8):55-60; discussion 60-2, 65. PubMed ID: 1834153
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates for breast cancer.
Pavlakis N; Stockler M
Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
[TBL] [Abstract][Full Text] [Related]
17. Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer.
Small EJ; Smith MR; Seaman JJ; Petrone S; Kowalski MO
J Clin Oncol; 2003 Dec; 21(23):4277-84. PubMed ID: 14581438
[TBL] [Abstract][Full Text] [Related]
18. [Is pamidronate or clodronate better?].
Adam Z
Vnitr Lek; 2002 Apr; 48(4):357. PubMed ID: 12075601
[No Abstract] [Full Text] [Related]
19. [The role of bisphosphonate in the treatment of bone metastases from prostate cancer].
Sallami S; Ben Rhouma S; Cherif K; Benrais N; Horchani A
Tunis Med; 2012 Jul; 90(7):507-11. PubMed ID: 22811222
[TBL] [Abstract][Full Text] [Related]
20. Aredia: the once-monthly infusion for the treatment of bone metastases.
Lipton A
Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S1-5. PubMed ID: 9801852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
